<DOC>
	<DOCNO>NCT02493205</DOCNO>
	<brief_summary>The Holding Area LINQ Trial clinical trial design compare benefit conduct impant procedure hold area hospital operating room v cardiac catheterization/electrophysiology laboratory .</brief_summary>
	<brief_title>The Holding Area LINQ ( Reveal LINQ Insertable Cardiac Monitor ) Trial Prospective , Non-randomized , Single Center Post-market Clinical Trial</brief_title>
	<detailed_description>The Holding Area LINQ Trial prospective , non-randomized , single center post-market clinical trial design occur hold area hospital operating room cardiac catheterization/electrophysiology laboratory . The primary objective characterize rate procedure-related complication within 90 day implant procedure require resolution surgical intervention . Twenty ( 20 ) patient establish clinical indication LINQ ICM ( Reveal LINQ Insertable Cardiac Monitor ) implant use standard care technique procedure . Implants require take place hospital hold area rather traditional facility location hospital operating room , cardiac catheterization lab , electrophysiology lab . A physical description hold area small patient examination room separate patient exam bay wall door . There sink patient exam room , laminate flooring , ceiling A/C vent , wall mount Hemodynamic monitoring equipment , wall mount oxygen/suction line . Patient sedation limit local anesthetic and/or oral anti-anxiety medication . Intravenous access obtain emergency resuscitative measure . Due low complication rate type implant practical limitation sample size , formal hypothesis test trial . This study characterize procedure-related adverse event occur within 90 day implant procedure . Data collect implant , 7-10 day post-op visit , 90-day post-implant visit .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Patient indicate continuous arrhythmia monitoring Implantable Cardiac Monitor 2 . Patient willing undergo implant hold area set local anesthetic and/or oral antianxiety medication sedation ( 2 mg Valium Ativan ) patient request . 3 . Patient 18 year age old . 4 . Patient willing provide inform consent authorize disclosure personal health information accordance state national regulation . 1 . Patient reduce immune function otherwise high risk infection 2 . Patient recent ( within 30 day ) otherwise unresolved infection . 3 . Patient implant indicated implant pacemaker , Implantable Cardiac Device ( ICD ) , Cardiac Resyncronization Therapy ( CRT ) hemodynamic monitoring system . 4 . Patient participate another clinical trial may impact trial endpoint . 5 . Patient supertherapeutic INR &gt; 3.0 . 6 . Patient consider Principal Investigator and/or subinvestigator inappropriate trial reason . 7 . Patient 's life expectancy le 1 year . 8 . Patient pregnant . 9 . Patient unusual thoracic anatomy scar implant site may adversely affect success implant procedure . 10 . Inability comply plan trial procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Implantable Cardiac Monitor</keyword>
	<keyword>Stent</keyword>
</DOC>